|
Market Closed -
Nasdaq
01:30:00 01/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 39.63 USD | +1.30% |
|
-2.32% | +45.91% |
| Market Cap | 307.21Cr 264.51Cr 248.36Cr 226.71Cr 425.9Cr 29TCr 428.95Cr 2.94TCr 1.15TCr 15TCr 1.15TCr 1.13TCr 49TCr | P/E 2026 * |
-9.37x | P/E 2027 * | -9.32x |
|---|---|---|---|---|---|
| Enterprise Value | 240.98Cr 207.48Cr 194.82Cr 177.84Cr 334.08Cr 23TCr 336.47Cr 2.31TCr 898.19Cr 12TCr 904.79Cr 885.13Cr 38TCr | EV / Sales 2026 * |
1,212x | EV / Sales 2027 * | 204x |
| Free-Float |
99.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Celldex Therapeutics, Inc.
| 1 day | +1.30% | ||
| 1 week | -2.32% | ||
| Current month | +4.13% | ||
| 1 month | +4.13% | ||
| 3 months | +31.49% | ||
| 6 months | +36.94% | ||
| Current year | +45.91% |
| 1 week | 38.74 |  | 42.12 |
| 1 month | 37.05 | | 45.14 |
| Current year | 22.33 | | 45.14 |
| 1 year | 21.77 | | 45.14 |
| 3 years | 14.4 | | 53.18 |
| 5 years | 14.4 | | 57.2 |
| 10 years | 1.5 | | 75.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tibor Keler
CTO | Chief Tech/Sci/R&D Officer | 67 | 30/07/2014 |
Anthony Marucci
CEO | Chief Executive Officer | 64 | 01/09/2008 |
Sam Martin
DFI | Director of Finance/CFO | 55 | 01/04/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Marucci
BRD | Director/Board Member | 64 | 01/12/2008 |
Harry Penner
CHM | Chairman | 80 | 05/06/2025 |
Herbert Conrad
BRD | Director/Board Member | 93 | 01/03/2008 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/06/26 | Free | Executive/Senior Manager | 20,000 | 0.0255% | ||
| 25/06/26 | Free | Director | 26,000 | 0.0331% | ||
| 25/06/26 | Free | Chief Technology Officer | 57,000 | 0.0726% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.30% | -2.32% | +79.65% | +42.04% | 307.21Cr | |
| -1.23% | -1.91% | +0.98% | +17.94% | 5.05TCr | |
| -1.11% | -2.84% | +420.04% | +505.15% | 4.46TCr | |
| -0.21% | +0.53% | +36.88% | +16.32% | 4.31TCr | |
| -1.95% | -3.33% | +8.29% | +73.25% | 4.17TCr | |
| -0.94% | -1.77% | +18.34% | +46.84% | 3.32TCr | |
| -1.11% | -4.20% | +25.49% | +119.78% | 1.68TCr | |
| +6.10% | +4.40% | - | - | 1.63TCr | |
| +0.25% | -0.41% | +11.91% | +29.03% | 1.46TCr | |
| -1.12% | -2.35% | +76.50% | +37.47% | 1.39TCr | |
| Average | +0.01% | -1.43% | +75.34% | +98.65% | 2.78TCr | |
| Weighted average by Cap. | -0.55% | -1.07% | +88.84% | +121.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 19.88L 17.12L 16.07L 14.67L 27.56L 19Cr 27.76L 1.9Cr 74.1L 9.59Cr 74.65L 73.02L 32Cr | 1.19Cr 1.03Cr 96.38L 87.98L 1.65Cr 113.43Cr 1.66Cr 11Cr 4.44Cr 58Cr 4.48Cr 4.38Cr 190.45Cr |
| Net income | -32Cr -27Cr -26Cr -23Cr -44Cr -3.02TCr -44Cr -303.83Cr -118.21Cr -1.53TCr -119.08Cr -116.49Cr -5.07TCr | -36Cr -31Cr -29Cr -26Cr -49Cr -3.38TCr -50Cr -340.23Cr -132.37Cr -1.71TCr -133.35Cr -130.45Cr -5.67TCr |
| Net Debt | -66Cr -57Cr -54Cr -49Cr -92Cr -6.3TCr -92Cr -634.5Cr -246.87Cr -3.2TCr -248.68Cr -243.28Cr -11TCr | -64Cr -55Cr -52Cr -47Cr -88Cr -6.07TCr -89Cr -610.77Cr -237.64Cr -3.08TCr -239.38Cr -234.18Cr -10TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/26/01 | $39.63 | +1.30% | 6,96,906 |
| 28/26/28 | $39.12 | -3.31% | 4,24,938 |
| 27/26/27 | $40.46 | -0.27% | 4,50,009 |
| 26/26/26 | $40.57 | -1.58% | 5,40,668 |
| 25/26/25 | $41.22 | +1.60% | 5,50,919 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CLDX Stock
Select your edition
All financial news and data tailored to specific country editions
